AHIP hits hard on cost issue, using hepatitis C drug as example

May 22 2014NewsGuard 100/100 Score

Reuters:  U.S. Health Insurers Say Gilead Hepatitis C Drug Too Costly
The leading U.S. health insurance trade group on Tuesday hit out at the extremely high cost of new specialty medicines, accusing drugmakers of taking advantage of the insurance system by pricing products at unsustainable levels. The latest salvo in the war on escalating U.S. healthcare costs came from AHIP - America's Health Insurance Plans - and targeted Sovaldi, the new $84,000 hepatitis C treatment from Gilead Sciences Inc. (5/20).

http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Posted in: Disease/Infection News | Healthcare News | Pharmaceutical News

Tags: , , , , , , , , ,

Comments (0)

Suggested Reading

A tale of two states: Arizona and Florida diverge on how to expand kids’ health insurance
Reinsurance programs may increase costs for ACA marketplace enrollees
State COVID-19 vaccine mandates increased vaccine uptake among healthcare workers in 2021
California floats extending health insurance subsidies to all adult immigrants
40% of US cancer cases linked to lifestyle choices
Statins found to prevent chronic inflammation-related cancers by inhibiting interleukin-33
50 years of lifesaving vaccinations: WHO's EPI saves 154 million lives
Global and Local Efforts to Take Action Against Hepatitis

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback

You might also like...
Childhood vaccinations save trillions in societal costs while preventing millions of illnesses and deaths